 |
PDBsum entry 2or7
|
|
|
|
 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
|
|
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
|
|
|
|
|
|
|
|
|
Immune system
|
PDB id
|
|
|
|
2or7
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
References listed in PDB file
|
 |
|
Key reference
|
 |
|
Title
|
 |
Structures of t cell immunoglobulin mucin receptors 1 and 2 reveal mechanisms for regulation of immune responses by the tim receptor family.
|
 |
|
Authors
|
 |
C.Santiago,
A.Ballesteros,
C.Tami,
L.Martínez-Muñoz,
G.G.Kaplan,
J.M.Casasnovas.
|
 |
|
Ref.
|
 |
Immunity, 2007,
26,
299-310.
[DOI no: ]
|
 |
|
PubMed id
|
 |
|
 |
 |
|
Abstract
|
 |
|
The T cell immunoglobulin mucin (TIM) receptors are involved in the regulation
of immune responses, autoimmunity, and allergy. Structures of the N-terminal
ligand binding domain of the murine mTIM-1 and mTIM-2 receptors revealed an
immunoglobulin (Ig) fold, with four Cys residues bridging a distinctive CC' loop
to the GFC beta-sheet. The structures showed two ligand-recognition modes in the
TIM family. The mTIM-1 structure identified a homophilic TIM-TIM adhesion
interaction, whereas the mTIM-2 domain formed a dimer that prevented homophilic
binding. Biochemical, mutational, and cell adhesion analyses confirmed the
divergent ligand-binding modes revealed by the structures. Structural features
characteristic of mTIM-1 appear conserved in human TIM-1, which also mediated
homophilic interactions. The extracellular mucin domain enhanced binding through
the Ig domain, modulating TIM receptor functions. These results explain the
divergent immune functions described for the murine receptors and the role of
TIM-1 as a cell adhesion receptor in renal regeneration and cancer.
|
 |
 |
 |
|
 |
|
 |
Figure 3.
Figure 3. N-Terminal Domain Interactions in the TIM Receptors
(A and B) Ribbon diagrams of the two domains in the
asymmetric unit of the mTIM-2 (A) and mTIM-1 (B) crystals. Side
view of the dimer is displayed for mTIM-2, whereas a view along
the quasi-2-fold axis (2) is shown for mTIM-1. Molecules
presented in Figure 1 have the same coloring scheme, and the
neighboring molecules are in yellow. Side chains of residues
contributing to the dimer interfaces are included and some
central residues are labeled. Acetate ligand found in the mTIM-2
structure is black, water molecules are red spheres, and
hydrogen bonds are pink dashed cylinders. Asn residues to which
glycans link in mTIM-2 are green. Arrows represent the
hypothetical interaction of O-linked glycans from the C-terminal
mucin domain with residues at the β strand A, BC, and FG loops
of the interacting mTIM-1 domains (see also Figure S3). (C)
Self-association of the N-terminal IgV domains in solution.
SDS-PAGE under reducing conditions of mTIM-1, mTIM-2, and mTIM-4
domains untreated (−) or treated with the indicated BS^3
crosslinker concentration (mM). Treated ICAM-1 protein (IC1-2D)
known to dimerize at high concentration and a soluble fragment
of CD46 are also included. Size and migration of the molecular
weight marker is indicated. Crosslinked dimers are labeled with
an asterisk. No dimerization of the mTIM-4 IgV domain is seen
here or in the protein crystals (not shown). (D) Structural
alignment with residues at the dimer interface in yellow and
those at the center of the interacting molecules in blue. β
strands are represented by lines.
|
 |
Figure 7.
Figure 7. Ligand-Binding Surfaces in the IgV Domain of TIM-1
Receptors Surface representation of the mTIM-1 domain
structure. Surface involved in the homophilic interaction is
pink. Residues in a conformational epitope built by the tip of
the long CC′ loop and the FG loop onto the GFC β sheet are
colored red and orange, respectively. The surface where an
mkTIM-1 polymorphism (Lys88Gln) has been mapped is in blue. The
mutation identified the side of the domain recognized by a mAb
blocking HAV binding to its mkTIM-1 receptor (Feigelstock et
al., 1998a). Surface corresponding to the Asn residue to which
glycans will be linked in the primate TIM-1 receptors is green.
|
 |
|
 |
 |
|
The above figures are
reprinted
by permission from Cell Press:
Immunity
(2007,
26,
299-310)
copyright 2007.
|
 |
|
|
|
|
 |